Literature DB >> 21933628

Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.

Jun Xiong1, Xu Liao, Fu-shan Xue, Yu-jing Yuan, Qiang Wang, Jian-hua Liu.   

Abstract

OBJECTIVE: A general review was made of studies involving: (1) The experimental evidence of remote ischemic preconditioning (RIPC) and relative clinical studies, (2) The experimental and clinical evidences of remote ischemic postconditioning (RIPOC), (3) The potential mechanistic pathways underlying their protective effects. DATA SOURCES: The data used in this review were mainly from manuscripts listed in PubMed that were published in English from 1986 to 2010. The search terms were "myocardial ischemia reperfusion injury", "ischemia preconditioning", "ischemia postconditioning", "remote preconditioning" and "remote postconditioning". STUDY SELECTION: (1) Clinical and experimental evidence that both RIPC and RIPOC produce preservation of ischemia reperfusion injury (IRI) of myocardium and other organs, (2) Studies related to the potential mechanisms, by which remote ischemic conditioning protects myocardium against IRI.
RESULTS: Both RIPC and RIOPC have been shown to attenuate myocardial IRI in laboratory animals. Also, their cardioprotective effects have appeared in some clinical studies. Except the external, the detailed internal mechanisms of remote ischemic conditioning have been generally described. Through these descriptions better protocols can be developed to provide improved cardioprotective procedures.
CONCLUSIONS: Remote ischemic conditioning is an endogenous cardioprotective mechanism from outside the heart that protects against myocardial IRI and represents a general form of inter-organ protection. Remote ischemic conditioning may have an immense impact on clinical practice in the near future.

Entities:  

Mesh:

Year:  2011        PMID: 21933628

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  κ-Opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning.

Authors:  Ya-Chao Xu; Rui-Ping Li; Fu-Shan Xue; Xin-Long Cui; Shi-Yu Wang; Gao-Pu Liu; Gui-Zhen Yang; Chao Sun; Xu Liao
Journal:  J Anesth       Date:  2015-03-26       Impact factor: 2.078

2.  Effect of remote ischemic postconditioning in inflammatory changes of the lung parenchyma of rats submitted to ischemia and reperfusion.

Authors:  Rafael Cantero Dorsa; José Carlos Dorsa Vieira Pontes; Andréia Conceição Brochado Antoniolli; Guilherme Viotto Rodrigues da Silva; Ricardo Adala Benfatti; Carlos Henrique Marques dos Santos; Elenir Rose Cury Pontes; José Anderson Souza Goldiano
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

3.  Ischemic preconditioning attenuates lipid peroxidation and apoptosis in the cecal ligation and puncture model of sepsis.

Authors:  Cimen Gülben Olguner; Uğur Koca; Emel Altekin; Bekir Uğur Ergür; Seden Duru; Pelin Girgin; Aydin Taşdöğen; Kerim Gündüz; Seda Güzeldağ; Muhammed Akkuş; Serap Cilaker Micili
Journal:  Exp Ther Med       Date:  2013-04-02       Impact factor: 2.447

4.  Effects of Renal Ischemic Postconditioning on Myocardial Ultrastructural Organization and Myocardial Expression of Bcl-2/Bax in Rabbits.

Authors:  Wen-Zhong Zhang; Rong Li; Song Liu; Ji-Dong Zhang; Xian-Feng Ning; Shang-Lang Cai
Journal:  Biomed Res Int       Date:  2016-12-20       Impact factor: 3.411

5.  Effects of remote ischemic post-conditioning on platelet activation of AMI patients.

Authors:  Yun-Xia Qian; Ke-Sheng Dai; Li-Li Zhao; Xiang-Jun Yang
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

6.  Effects of Remote Ischaemic Preconditioning on the Internal Thoracic Artery Nitric Oxide Synthase Isoforms in Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Aleksandra Jankovic; Tamara Zakic; Miroslav Milicic; Dragana Unic-Stojanovic; Andjelika Kalezic; Aleksandra Korac; Miomir Jovic; Bato Korac
Journal:  Antioxidants (Basel)       Date:  2021-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.